Clinical Trial Update: Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult Females [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating single-dose and multiple-dose safety and tolerability of PF-04856883 in adult females with type 2 diabetes; completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Endocrine System Disease
• Glucose Metabolism Disorder
• Metabolic Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• PF-04856883 (PF-04856883)

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2018-02-09